These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 189424
1. [Bone-marrow biopsy in chronic myeloid leukemia. Value of the initial examination]. Devred C, Bentata J, Diebold J, Bernadou A, Bilski-Pasquier G. Sem Hop; 1977 Jan 09; 53(2):119-24. PubMed ID: 189424 [Abstract] [Full Text] [Related]
2. [Bone-marrow biopsy in chronic myeloid leukemia. Significance during development]. Devred C, Bentata J, Diebold J, Bernadou A, Bilski-Pasquier G. Sem Hop; 1977 Jan 09; 53(2):125-31. PubMed ID: 189425 [Abstract] [Full Text] [Related]
3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A. Pathobiology; 2007 Jan 09; 74(2):97-114. PubMed ID: 17587881 [Abstract] [Full Text] [Related]
4. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases]. Seewann HL. Wien Med Wochenschr Suppl; 1986 Jan 09; 100():1-24. PubMed ID: 3471009 [Abstract] [Full Text] [Related]
5. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders]. Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M. Recenti Prog Med; 2003 Jan 09; 94(7-8):314-20. PubMed ID: 12868237 [Abstract] [Full Text] [Related]
6. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression. Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K. Eur J Haematol; 2004 Jun 09; 72(6):410-5. PubMed ID: 15128419 [Abstract] [Full Text] [Related]
7. [Bone marrow biopsy in myeloproliferative syndromes: prognostic value of cellular quantification]. Esquivias López-Cuervo JJ, Romero Aguilar A, González García J. Sangre (Barc); 1990 Apr 09; 35(2):98-101. PubMed ID: 2363101 [Abstract] [Full Text] [Related]
8. [The value of the initial bone biopsy in chronic myeloproliferative syndromes. Review of 80 cases]. Ortuño F, Zuazu I, Bordes R, Brunet S, Puig J, Ayats R. Sangre (Barc); 1989 Apr 09; 34(2):117-25. PubMed ID: 2667169 [Abstract] [Full Text] [Related]
9. [Emperipolesis in megakaryocytes in patients with thrombocytosis in the course of myeloproliferative disorders]. Bobik R, Podolak-Dawidziak M, Kiełbiński M, Jeleń M, Wróbel T. Acta Haematol Pol; 1995 Apr 09; 26(2):179-83. PubMed ID: 7653223 [Abstract] [Full Text] [Related]
10. The value of bone marrow biopsy in chronic myeloid leukaemia. Seewann HL, Lehnert M, Jüttner F. Haematologia (Budap); 1983 Apr 09; 16(1-4):67-72. PubMed ID: 6592124 [Abstract] [Full Text] [Related]
11. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy]. Matolcsy A, Kónya T, Wéber E. Orv Hetil; 1992 Jun 28; 133(26):1617-20, 1625-6. PubMed ID: 1614699 [Abstract] [Full Text] [Related]
12. Myelofibrosis in the myeloproliferative disorders. Ellis JT, Peterson P. Prog Clin Biol Res; 1984 Jun 28; 154():19-42. PubMed ID: 6382293 [Abstract] [Full Text] [Related]
18. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia. Xubo G, Xingguo L, Xianguo W, Rongzhen X, Xibin X, Lin W, Lei Z, Xiaohong Z, Genbo X, Xiaoying Z. Eur J Haematol; 2009 Oct 28; 83(4):292-301. PubMed ID: 19500135 [Abstract] [Full Text] [Related]